C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 85 filers reported holding C4 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,427 | -22.3% | 25,932 | +45.9% | 0.00% | – |
| Q4 2022 | $104,843 | -31.5% | 17,770 | +1.6% | 0.00% | – |
| Q3 2022 | $153,000 | +10.1% | 17,489 | -5.1% | 0.00% | – |
| Q2 2022 | $139,000 | -78.7% | 18,428 | -31.7% | 0.00% | – |
| Q1 2022 | $654,000 | -63.8% | 26,990 | -51.8% | 0.00% | -100.0% |
| Q4 2021 | $1,805,000 | +67.1% | 56,040 | +131.7% | 0.00% | 0.0% |
| Q3 2021 | $1,080,000 | +30.4% | 24,186 | +10.6% | 0.00% | – |
| Q2 2021 | $828,000 | +210.1% | 21,859 | +203.0% | 0.00% | – |
| Q1 2021 | $267,000 | +2.7% | 7,214 | -8.2% | 0.00% | – |
| Q4 2020 | $260,000 | – | 7,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |